2011 to 2020 saw increase in annual prescription meds expenditures
Apr 15, 2024
Metabolic agents were the most costly category; antidiabetic agents were the mostly costly therapeutic area.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Diabetes complications more common in patients not living in urban areas
Mar 27, 2024
The findings were seen for residents of remote areas and small towns compared with those living in cities.
Insulin out-of-pocket cost caps do not increase insulin use
Mar 26, 2024
Caps are associated with a reduction in insulin costs, mainly driven by patients enrolled in health savings accounts.
Fresh, delivered produce tied to improvements in CVD risk factors
Mar 22, 2024
Significant improvements were seen for produce consumption, physical activity, non-high-density lipoprotein cholesterol and HbA1c.
Heart attack survivorship tied to long-term health consequences
Mar 04, 2024
An increased risk was seen for atrial fibrillation and cerebrovascular disease, among others.
Position statement addresses optimal management of diabetes
Feb 21, 2024
Tools available to help healthcare providers include guided communication styles and clinical screening tools for psychosocial conditions.
Exercise intensity, duration can affect CKD risk in obesity, type 2 diabetes
Feb 07, 2024
An inverse link was seen for total moderate-to-vigorous physical activity and MVPA accumulated in bouts of ≥10 minutes with progression to chronic kidney disease in overweight/obese adults with type...
Type 2 diabetes remission likely with weight loss after diagnosis
Jan 23, 2024
An increased likelihood of diabetes remission and a reduced risk for returning to hyperglycemia were seen with weight loss in a year after diagnosis.
FDA finds no evidence linking Wegovy, Ozempic to suicidal behaviors
Jan 12, 2024
The agency, however, noted that officials cannot rule out that “a small risk may exist,” and said it will continue to investigate.
